AGR2 and pancreatic ductal adenocarcinoma: Disruption of the AGR2-RNAPII complex in the KC pancreatic ductal adenocarcinoma mouse model led to activation of p53, upregulation of p-H2axS139, and suppression of tumor growth with no adverse side effects on healthy tissues.